SCHEMBL1167765

SCHEMBL1167765

CCON(S(=O)(=O)O)S(=O)(=O)O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871757 0.97 CA1 (0.31) CA1CA2
SCHEMBL8047573 0.97 CA1 (0.31) CA1CA2
Hydrochloric Acid SCHEMBL7193688 0.95
SCHEMBL28298849 0.72 CA2 (0.32) CA1CA2
SCHEMBL8608352 0.72 TP53 (0.34)
Sulfuric Acid SCHEMBL28101970 0.69 TP53 (0.31)
SCHEMBL4848140 0.69 CA2 (0.30) CA2
SCHEMBL24090525 0.67
SCHEMBL1534181 0.67
Sulfuric Acid SCHEMBL6748599 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7160674-B2 Photographic chemicals bundle A&O IMAGINING SOLUTIONS GMBH (DE) 2007-01-09 US claimed
EP-1464683-B1 Ink-Jet Ink TETENAL AG & CO KG (DE) 2006-09-20 EP claimed
EP-1513009-A1 Container for photochemicals AgfaPhoto GmbH (DE) 2005-03-09 EP claimed
US-20050048420-A1 Photographic chemicals bundle AGFA-GEVAERT N.V. (BE) 2005-03-03 US claimed
EP-0851289-A2 Colour developer Tetenal Photowerk GmbH & Co (DE) 1998-07-01 EP claimed
EP-4700821-A1 TREATMENT SOLUTION AND METHOD FOR TREATING OBJECT TO BE TREATED FUJIFILM Corporation (JP) 2026-02-25 EP disclosed
US-20260028558-A1 TREATMENT LIQUID AND METHOD FOR TREATING OBJECT TO BE TREATED FUJIFILM CORP (JP) 2026-01-29 US disclosed
US-12481218-B2 Treatment liquid, method for washing substrate, and method for removing resist FUJIFILM CORPORATION (JP) 2025-11-25 US disclosed
US-12441965-B2 Treatment liquid and substrate washing method FUJIFILM CORPORATION (JP) 2025-10-14 US disclosed
US-20250215126-A1 COMPOSITION, SUBSTRATE TREATMENT METHOD, MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE, AND COMPOUND FUJIFILM CORPORATION (JP) 2025-07-03 US disclosed
US-12275921-B2 Treatment liquid and substrate treatment method FUJIFILM CORPORATION (JP) 2025-04-15 US disclosed
CN-115989314-B Treatment liquid and method for treating substrate 富士胶片株式会社 2025-04-15 CN disclosed
US-5466563-A CONTINUOUS PROCESSING FUJI PHOTO FILM CO., LTD. (JP) 1995-11-14 US disclosed
US-5391466-A Ferric complex KONICA CORPORATION (JP) 1995-02-21 US disclosed
EP-0601393-A1 Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1994-06-15 EP disclosed
EP-0599620-A1 Chemical compositions and a processing method using the same for processing silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1994-06-01 EP disclosed
EP-0597476-A1 Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1994-05-18 EP disclosed
US-5217854-A Aromatic primary amine FUJI PHOTO FILM CO., LTD. (JP) 1993-06-08 US disclosed
EP-0488233-A1 Method of processing silver halide photograhic material FUJI PHOTO FILM CO., LTD. (JP) 1992-06-03 EP disclosed
EP-0456220-A2 Vacuum packaged color developing composition FUJI PHOTO FILM CO., LTD. (JP) 1991-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028558-A1 TREATMENT LIQUID AND METHOD FOR TREATING OBJECT TO BE TREATED AOC1, EPCAM, AOC2 CA1 331/4885CA2 555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.